Abstract: A dry flower, and a process for producing the same, coated on its surface with a polymer film of (R.sup.1 HSiO).sub.a (R.sup.2 R.sup.3 SiO).sub.b (R.sup.4 R.sup.5 R.sup.6 SiO.sub.1/2).sub.c or (2) a film of one or more polymers selected from (i) photopolymerizable polymers, (ii) silane coupling agent polymers, and (iii) copolymers of photopolymerizable monomers and silane coupling agents.

Abstract: A complex material of a hydrophilic polymer-silicate mineral comprising a carboxyl group containing hydrophilic polymer and a water swellable silicate mineral, and having a new absorption spectrum not existing in both starting materials in the IR-ray absorption spectrum within the range of 1000 to 1300 cm.sup.-1, and pharmaceutical and cosmetic compositions comprising same.

Abstract: To provide a base suitable for a controlled release preparation and the controlled release preparation. A bioactive substance(s) is introduced in a poly-ion complex of hyaluronic acid and a cationic polyacrylic acid derivative(s).

Abstract: A metal thin layer type magnetic recording medium is disclosed, comprising a non-magnetic support having formed thereon (1) a ferromagnetic metal thin layer or (2) a ferromagnetic metal thin layer and a protective layer formed on the ferromagnetic metal thin layer, wherein a layer comprising a polymer of at least one chain or cyclic silicone compound which is formed on the surface of the ferromagnetic metal thin layer or the protective layer by bringing the silicone compound into contact with the surface in the vapor phase is provided on the surface; the atomic number ratio (Si.sub.2p /Co.sub.2p.sup.3/2) of Si in the polymer is from 0.02 to 0.30; and the silicone compound is represented by formula (I):(R.sup.1 HSiO).sub.a (R.sup.2 R.sup.3 SiO).sub.b (R.sup.4 R.sup.5 R.sup.6 SiO.sub.1/2).sub.c (I)wherein R.sup.1, R.sup.2, and R.sup.3 each represents a hydrogen atom or a substituted or unsubstituted hydrocarbon group having from 1 to 10 carbon atoms, R.sup.1, R.sup.2, and R.sup.

Abstract: A percutaneous absorption promoting agent comprising (A) at least one anionic surfactant and one or two or more of surfactants having a nitrogen atom in the molecule other than anionic surfactants, (B) one or two or more of anionic surfactants and one or two or more of nonionic surfactants not having a nitrogen atom in the molecule, (C) one or two or more of surfactants selected from the group consisting of amphoteric surfactant and semi-polar surfactants and at least one nonionic surfactant having a nitrogen atom in the molecule, (D) one or two or more of surfactants selected from the group consisting of nonionic surfactants, amphoteric surfactants, semi-polar surfactants and cationic surfactants having a nitrogen atom in the molecule, and one or two or more of nonionic surfactants not having a nitrogen atom in the molecule, or (E) an amine oxide as the active ingredient, and a dermatological preparation containing these percutaneous absorption promoting agent and drug components.

Abstract: Provisions are made so that an SPF value having high correlation with an in vivo SPF value can be calculated in vitro using a common calculation equation regardless of the material type used. Transmitted UV intensities I(.lambda.) are corrected by respective erythemal effectiveness coefficients EE(.lambda.) to calculate an erythema-inducing UV intensity EUI, and the elements of I(.lambda.) from .lambda.=320 to 400 nm are summed to calculate a transmitted UV-A intensity; then, from the ratio UV-A/EUI, a theoretical value .alpha..sub.TH is calculated for the base .alpha. of a photoaugmentative effectiveness .alpha..sup.UVA, and using EUI.times..alpha..sub.TH.sup.UVA, an ultimate theoretical value EUI.sub.UL of EUI is calculated. When EUI.sub.UL is larger than 75, the SPF value is calculated from 1350/EUI.sub.UL ; otherwise, the SPF value is calculated using an empirical equation.

Abstract: An external skin treatment composition containing (I) vitamin A (retinol) and (II) as a stabilizer, a chelating agent/a polysaccharide, an oil, polyethylene (propylene) glycol, a hydroxy carboxylate, a neutral amino acid salt, an oil-soluble antioxidant/EDTA/a benzophenone compound, an oil-soluble antioxidant/an acid/a benzophenone compound, an inclusion compound of cyclodextrin including an antioxidant and/or an ultraviolet absorber, butanediol and/or an oil-soluble antioxidant, a water-soluble benzophenone compound, a basic amino acid and the salt thereof, an acidic amino acid and the salt thereof, a polar oil, a water-swellable clay mineral.

Abstract: An external dermatological composition comprising a salt of L-arginine-L-aspartic acid and a pharmacologically acceptable carrier therefor.

Abstract: A silicone-type benzophenone derivative represented by Formula 1 below, an ultraviolet light absorbent and an endermic liniment which contains it. ##STR1## The silicone-type benzophenone derivative of the present invention exhibits a superior ability to absorb UV-A and UV-B and is compatible with silicone-type bases.

Abstract: An emulsified composition for treating the skin containing diclofenac sodium, a fatty acid and a dialkyl carboxylate, as essential components.

Abstract: A skin irritation alleviation agent composed of a polyoxyalkylene-modified organopolysiloxane is provided. Various compositions including skin external application compositions, cosmetic or similar compositions (e.g., an adhesive composition for a false eyelash, a decolorant composition, a depilatory composition, and an eyeliner composition) containing a polyoxyalkylene-modified organosiloxane are also provided. This alleviation agent has a low skin irritation effect and extremely high safety factor when used on the human body.

Abstract: A cosmetic composition comprising an inclusion product having a slightly water-soluble component with a hydroxyalkylated cyclodextrin formulated therein.